Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and beauty - Technological Innovation of Hongxinglong Central Hospital
Technological Innovation of Hongxinglong Central Hospital
Since 2002, the hospital has focused on "hospital advantages, specialties and specialties", made breakthroughs in minimally invasive surgery and microsurgery, and made great efforts in scientific and technological innovation to build a new brand of Hongxinglong Central Hospital. Thoracoscopic treatment of pulmonary bullae, superficial lung tumors and hemopneumothorax is unique in thoracic surgery. Mitral valve replacement and tricuspid valvuloplasty under cardiopulmonary bypass were also performed. More than 8,500 cases of laparoscopic cholecystectomy, subtotal gastrectomy, appendectomy, hysterectomy and ovariectomy were performed in obstetrics and gynecology in general surgery, and splenectomy plus pericardial devascularization and proximal spleen-stomach vein shunt were successfully performed in patients with portal hypertension due to liver cirrhosis. More than 300 cases of meniscus injury and osteoarthritis were performed in orthopedic surgery under arthroscopy, and more than 300 cases were performed with anterior and posterior cervical intervertebral disc removal, shallow decompression and artificial joint replacement 100. More than 4,300 cases of plasma prostatectomy, laparoscopic nephrectomy and nephrectomy have achieved good results. Microsurgery has carried out various brain tumor resection, aneurysm clipping and embolization, microsurgery has carried out replantation of severed palm, and ophthalmology has carried out cataract extraction to fill the gap in reclamation area. Amniotic membrane covering and tympanoplasty were performed in otolaryngology department to improve patients' vision and hearing. Patients with thyroid cancer underwent modified neck lymph node dissection and radical laryngectomy. At the same time, surgery, chemotherapy, interventional therapy, radiotherapy and other systematic treatments were taken. The interventional therapy of acute cerebral infarction under DSA in neurology department has achieved good results. Four new technologies such as low molecular weight heparin in the treatment of acute coronary syndrome were developed in hematology department, and 3 papers were published in national magazines. Internal medicine has carried out intracardiac radiofrequency ablation, coronary angiography, balloon dilatation and stent implantation to treat more than 2300 cases of coronary artery stenosis. Liver biopsy is carried out in the B-ultrasound room of physical diagnosis and treatment department, and lung biopsy under CT provides accurate and reliable basis for clinical diagnosis.

The interventional treatment center in the hospital has mature technology, and can install coronary stents, artificial pacemakers, atrial-ventricular septal defects and patent ductus arteriosus blocking umbrellas. Interventional treatments such as radiofrequency ablation, lung cancer perfusion chemotherapy, liver cancer perfusion chemotherapy, lumbar disc herniation, aseptic necrosis of femoral head and hysteromyoma were carried out. The radiotherapy department of the hospital is well-equipped and advanced in radiotherapy technology, and it is in a leading position in Sanjiang area.